Pentamidine Isethionate: Difference between revisions
| Line 17: | Line 17: | ||
''' [[Pentamidine Isethionate description|Description]]''' | ''' [[Pentamidine Isethionate description|Description]]''' | ||
'''| [[Pentamidine Isethionate clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Pentamidine Isethionate clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Pentamidine Isethionate indications and usage|Indications and Usage]]''' | '''| [[Pentamidine Isethionate indications and usage|Indications and Usage]]''' | ||
'''| [[Pentamidine Isethionate contraindications|Contraindications]]''' | '''| [[Pentamidine Isethionate contraindications|Contraindications]]''' | ||
Revision as of 10:00, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Pentamidine (formulated as a salt, pentamidine diisethionate or dimesilate) is an antimicrobial medication given for prevention and treatment of Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (formerly known as Pneumocystis carinii), a severe interstitial type of pneumonia often seen in patients with HIV infection. The drug is also the mainstay of treatment for stage I infection with Trypanosoma brucei gambiense (West African Trypanosomiasis).
Category
US Brand Names
PENTAM 300®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages